カテゴリー： QYResearch, 世界

医薬品CDMOサービスの世界市場：規模・現状・予測

◆英語タイトル：Global Pharmaceutical CDMO Services Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18817
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：96
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、医薬品CDMOサービスの世界市場について調査・分析し、医薬品CDMOサービスの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（原薬開発および製造、専門サービス、ラボベースサービス）、用途別（革新的医学、特許取得済み薬剤、特許期限切れ薬剤）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の医薬品CDMOサービス市場動向
・主要企業別マーケットシェア
・医薬品CDMOサービスの種類別市場規模2014-2019
（原薬開発および製造、専門サービス、ラボベースサービス）
・医薬品CDMOサービスの用途別市場規模2014-2019
（革新的医学、特許取得済み薬剤、特許期限切れ薬剤）
・医薬品CDMOサービスの北米市場：主要企業・種類別/用途別市場規模
・医薬品CDMOサービスのヨーロッパ市場：主要企業・種類別/用途別市場規模
・医薬品CDMOサービスの中国市場：主要企業・種類別/用途別市場規模
・医薬品CDMOサービスの日本国内市場：主要企業・種類別/用途別市場規模
・医薬品CDMOサービスの東南アジア市場：主要企業・種類別/用途別市場規模
・医薬品CDMOサービスのインド市場：主要企業・種類別/用途別市場規模
・医薬品CDMOサービスの中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Recipharm AB、AMRI Global、Patheon N.V.、Aenova Group、Catalent, Inc.、Amatsigroup、WuXi AppTec Group、Strides Pharma Science Limited、Piramal Pharma Solutions、Siegfried Ltd、Fareva Group、FAMAR Health Care Services）
・医薬品CDMOサービスの市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.In 2018, the global Pharmaceutical CDMO Services market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pharmaceutical CDMO Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical CDMO Services development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services

Market segment by Type, the product can be split into
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services

Market segment by Application, split into
Innovative Medicine
Patented Drug
Patent Expired Drug

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pharmaceutical CDMO Services status, future forecast, growth opportunity, key market and key players.
To present the Pharmaceutical CDMO Services development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pharmaceutical CDMO Services are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Substance Development and Manufacturing
1.4.3 Specialized Services
1.4.4 Lab-based Services
1.5 Market by Application
1.5.1 Global Pharmaceutical CDMO Services Market Share by Application (2019-2025)
1.5.2 Innovative Medicine
1.5.3 Patented Drug
1.5.4 Patent Expired Drug
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pharmaceutical CDMO Services Market Size
2.2 Pharmaceutical CDMO Services Growth Trends by Regions
2.2.1 Pharmaceutical CDMO Services Market Size by Regions (2019-2025)
2.2.2 Pharmaceutical CDMO Services Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Pharmaceutical CDMO Services Market Size by by Players
3.1.1 Global Pharmaceutical CDMO Services Revenue by by Players (2014-2019)
3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by by Players (2014-2019)
3.1.3 Global Pharmaceutical CDMO Services Market Concentration Ratio (CR5 and HHI)
3.2 Pharmaceutical CDMO Services Key Players Head office and Area Served
3.3 Key Players Pharmaceutical CDMO Services Product/Solution/Service
3.4 Date of Enter into Pharmaceutical CDMO Services Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pharmaceutical CDMO Services Market Size by Type (2014-2019)
4.2 Global Pharmaceutical CDMO Services Market Size by Application (2014-2019)

5 North America
5.1 North America Pharmaceutical CDMO Services Market Size (2014-2019)
5.2 Pharmaceutical CDMO Services Key Players in North America
5.3 North America Pharmaceutical CDMO Services Market Size by Type
5.4 North America Pharmaceutical CDMO Services Market Size by Application

6 Europe
6.1 Europe Pharmaceutical CDMO Services Market Size (2014-2019)
6.2 Pharmaceutical CDMO Services Key Players in Europe
6.3 Europe Pharmaceutical CDMO Services Market Size by Type
6.4 Europe Pharmaceutical CDMO Services Market Size by Application

7 China
7.1 China Pharmaceutical CDMO Services Market Size (2014-2019)
7.2 Pharmaceutical CDMO Services Key Players in China
7.3 China Pharmaceutical CDMO Services Market Size by Type
7.4 China Pharmaceutical CDMO Services Market Size by Application

8 Japan
8.1 Japan Pharmaceutical CDMO Services Market Size (2014-2019)
8.2 Pharmaceutical CDMO Services Key Players in Japan
8.3 Japan Pharmaceutical CDMO Services Market Size by Type
8.4 Japan Pharmaceutical CDMO Services Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pharmaceutical CDMO Services Market Size (2014-2019)
9.2 Pharmaceutical CDMO Services Key Players in Southeast Asia
9.3 Southeast Asia Pharmaceutical CDMO Services Market Size by Type
9.4 Southeast Asia Pharmaceutical CDMO Services Market Size by Application

10 India
10.1 India Pharmaceutical CDMO Services Market Size (2014-2019)
10.2 Pharmaceutical CDMO Services Key Players in India
10.3 India Pharmaceutical CDMO Services Market Size by Type
10.4 India Pharmaceutical CDMO Services Market Size by Application

11 Central & South America
11.1 Central & South America Pharmaceutical CDMO Services Market Size (2014-2019)
11.2 Pharmaceutical CDMO Services Key Players in Central & South America
11.3 Central & South America Pharmaceutical CDMO Services Market Size by Type
11.4 Central & South America Pharmaceutical CDMO Services Market Size by Application

12 International Players Profiles
12.1 Recipharm AB
12.1.1 Recipharm AB Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pharmaceutical CDMO Services Introduction
12.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2014-2019))
12.1.5 Recipharm AB Recent Development
12.2 AMRI Global
12.2.1 AMRI Global Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pharmaceutical CDMO Services Introduction
12.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2014-2019)
12.2.5 AMRI Global Recent Development
12.3 Patheon N.V.
12.3.1 Patheon N.V. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pharmaceutical CDMO Services Introduction
12.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2014-2019)
12.3.5 Patheon N.V. Recent Development
12.4 Aenova Group
12.4.1 Aenova Group Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pharmaceutical CDMO Services Introduction
12.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2014-2019)
12.4.5 Aenova Group Recent Development
12.5 Catalent, Inc.
12.5.1 Catalent, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pharmaceutical CDMO Services Introduction
12.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2014-2019)
12.5.5 Catalent, Inc. Recent Development
12.6 Amatsigroup
12.6.1 Amatsigroup Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pharmaceutical CDMO Services Introduction
12.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2014-2019)
12.6.5 Amatsigroup Recent Development
12.7 WuXi AppTec Group
12.7.1 WuXi AppTec Group Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pharmaceutical CDMO Services Introduction
12.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2014-2019)
12.7.5 WuXi AppTec Group Recent Development
12.8 Strides Pharma Science Limited
12.8.1 Strides Pharma Science Limited Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pharmaceutical CDMO Services Introduction
12.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2014-2019)
12.8.5 Strides Pharma Science Limited Recent Development
12.9 Piramal Pharma Solutions
12.9.1 Piramal Pharma Solutions Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pharmaceutical CDMO Services Introduction
12.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2014-2019)
12.9.5 Piramal Pharma Solutions Recent Development
12.10 Siegfried Ltd
12.10.1 Siegfried Ltd Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pharmaceutical CDMO Services Introduction
12.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2014-2019)
12.10.5 Siegfried Ltd Recent Development
12.11 Fareva Group
12.12 FAMAR Health Care Services

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Pharmaceutical CDMO Services Key Market Segments
Table Key Players Pharmaceutical CDMO Services Covered
Table Global Pharmaceutical CDMO Services Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Drug Substance Development and Manufacturing Figures
Table Key Players of Drug Substance Development and Manufacturing
Figuer Specialized Services Figures
Table Key Players of Specialized Services
Figuer Lab-based Services Figures
Table Key Players of Lab-based Services
Table Global Pharmaceutical CDMO Services Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Pharmaceutical CDMO Services Market Share by Application in 2018 & 2025
Figure Innovative Medicine Case Studies
Figure Patented Drug Case Studies
Figure Patent Expired Drug Case Studies
Figure Pharmaceutical CDMO Services Report Years Considered
Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Pharmaceutical CDMO Services Market Size by Regions 2019-2025 (Million US$)
Table Global Pharmaceutical CDMO Services Market Size by Regions 2019-2025 (Million US$)
Table Global Pharmaceutical CDMO Services Market Share by Regions 2014-2019
Figure Global Pharmaceutical CDMO Services Market Share by Regions 2014-2019
Figure Global Pharmaceutical CDMO Services Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Pharmaceutical CDMO Services Revenue by by Players (2014-2019) (Million US$)
Table Global Pharmaceutical CDMO Services Market Share by by Players (2014-2019)
Figure Global Pharmaceutical CDMO Services Market Share by by Players in 2018
Table Global Pharmaceutical CDMO Services by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Pharmaceutical CDMO Services Product/Solution/Service
Table Date of Enter into Pharmaceutical CDMO Services Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Pharmaceutical CDMO Services Market Size by Type (2014-2019) (Million US$)
Table Global Pharmaceutical CDMO Services Market Size Share by Type (2014-2019)
Figure Global Pharmaceutical CDMO Services Market Size Market Share by Type (2014-2019)
Table Global Pharmaceutical CDMO Services Market Size by Application (2014-2019) (Million US$)
Table Global Pharmaceutical CDMO Services Market Size Share by Application (2014-2019)
Figure Global Pharmaceutical CDMO Services Market Size Market Share by Application (2014-2019)
Figure Global Pharmaceutical CDMO Services Revenue Market Share by Application in 2018
Figure North America Pharmaceutical CDMO Services Market Size 2014-2019 (Million US$)
Table North America Key Players Pharmaceutical CDMO Services Revenue (2018-2019) (Million US$)
Table North America Key Players Pharmaceutical CDMO Services Market Share (2018-2019)
Table North America Pharmaceutical CDMO Services Market Size by Type 2014-2019 (Million US$)
Table North America Pharmaceutical CDMO Services Market Share by Type 2014-2019
Table North America Pharmaceutical CDMO Services Market Size by Application 2014-2019 (Million US$)
Table North America Pharmaceutical CDMO Services Market Share by Application 2014-2019
Figure Europe Pharmaceutical CDMO Services Market Size 2014-2019 (Million US$)
Table Europe Key Players Pharmaceutical CDMO Services Revenue (2018-2019) (Million US$)
Table Europe Key Players Pharmaceutical CDMO Services Market Share (2018-2019)
Table Europe Pharmaceutical CDMO Services Market Size by Type 2014-2019 (Million US$)
Table Europe Pharmaceutical CDMO Services Market Share by Type 2014-2019
Table Europe Pharmaceutical CDMO Services Market Size by Application 2014-2019 (Million US$)
Table Europe Pharmaceutical CDMO Services Market Share by Application 2014-2019
Figure China Pharmaceutical CDMO Services Market Size 2014-2019 (Million US$)
Table China Key Players Pharmaceutical CDMO Services Revenue (2018-2019) (Million US$)
Table China Key Players Pharmaceutical CDMO Services Market Share (2018-2019)
Table China Pharmaceutical CDMO Services Market Size by Type 2014-2019 (Million US$)
Table China Pharmaceutical CDMO Services Market Share by Type 2014-2019
Table China Pharmaceutical CDMO Services Market Size by Application 2014-2019 (Million US$)
Table China Pharmaceutical CDMO Services Market Share by Application 2014-2019
Figure Japan Pharmaceutical CDMO Services Market Size 2014-2019 (Million US$)
Table Japan Key Players Pharmaceutical CDMO Services Revenue (2018-2019) (Million US$)
Table Japan Key Players Pharmaceutical CDMO Services Market Share (2018-2019)
Table Japan Pharmaceutical CDMO Services Market Size by Type 2014-2019 (Million US$)
Table Japan Pharmaceutical CDMO Services Market Share by Type 2014-2019
Table Japan Pharmaceutical CDMO Services Market Size by Application 2014-2019 (Million US$)
Table Japan Pharmaceutical CDMO Services Market Share by Application 2014-2019
Figure Southeast Asia Pharmaceutical CDMO Services Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Pharmaceutical CDMO Services Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Pharmaceutical CDMO Services Market Share (2018-2019)
Table Southeast Asia Pharmaceutical CDMO Services Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Pharmaceutical CDMO Services Market Share by Type 2014-2019
Table Southeast Asia Pharmaceutical CDMO Services Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Pharmaceutical CDMO Services Market Share by Application 2014-2019
Figure India Pharmaceutical CDMO Services Market Size 2014-2019 (Million US$)
Table India Key Players Pharmaceutical CDMO Services Revenue (2018-2019) (Million US$)
Table India Key Players Pharmaceutical CDMO Services Market Share (2018-2019)
Table India Pharmaceutical CDMO Services Market Size by Type 2014-2019 (Million US$)
Table India Pharmaceutical CDMO Services Market Share by Type 2014-2019
Table India Pharmaceutical CDMO Services Market Size by Application 2014-2019 (Million US$)
Table India Pharmaceutical CDMO Services Market Share by Application 2014-2019
Figure Central & South America Pharmaceutical CDMO Services Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Pharmaceutical CDMO Services Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Pharmaceutical CDMO Services Market Share (2018-2019)
Table Central & South America Pharmaceutical CDMO Services Market Size by Type 2014-2019 (Million US$)
Table Central & South America Pharmaceutical CDMO Services Market Share by Type 2014-2019
Table Central & South America Pharmaceutical CDMO Services Market Size by Application 2014-2019 (Million US$)
Table Central & South America Pharmaceutical CDMO Services Market Share by Application 2014-2019
Table Recipharm AB Company Details
Table Recipharm AB Revenue in Pharmaceutical CDMO Services Business 2014-2019 (Million US$)
Figure Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Services Business (2014-2019)
Table Recipharm AB Recent Development
Table AMRI Global Company Details
Table AMRI Global Revenue in Pharmaceutical CDMO Services Business 2014-2019 (Million US$)
Figure AMRI Global Revenue Growth Rate in Pharmaceutical CDMO Services Business (2014-2019)
Table AMRI Global Recent Development
Table Patheon N.V. Company Details
Table Patheon N.V. Revenue in Pharmaceutical CDMO Services Business 2014-2019 (Million US$)
Figure Patheon N.V. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2014-2019)
Table Patheon N.V. Recent Development
Table Aenova Group Company Details
Table Aenova Group Revenue in Pharmaceutical CDMO Services Business 2014-2019 (Million US$)
Figure Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2014-2019)
Table Aenova Group Recent Development
Table Catalent, Inc. Company Details
Table Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business 2014-2019 (Million US$)
Figure Catalent, Inc. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2014-2019)
Table Catalent, Inc. Recent Development
Table Amatsigroup Company Details
Table Amatsigroup Revenue in Pharmaceutical CDMO Services Business 2014-2019 (Million US$)
Figure Amatsigroup Revenue Growth Rate in Pharmaceutical CDMO Services Business (2014-2019)
Table Amatsigroup Recent Development
Table WuXi AppTec Group Company Details
Table WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business 2014-2019 (Million US$)
Figure WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2014-2019)
Table WuXi AppTec Group Recent Development
Table Strides Pharma Science Limited Company Details
Table Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business 2014-2019 (Million US$)
Figure Strides Pharma Science Limited Revenue Growth Rate in Pharmaceutical CDMO Services Business (2014-2019)
Table Strides Pharma Science Limited Recent Development
Table Piramal Pharma Solutions Company Details
Table Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business 2014-2019 (Million US$)
Figure Piramal Pharma Solutions Revenue Growth Rate in Pharmaceutical CDMO Services Business (2014-2019)
Table Piramal Pharma Solutions Recent Development
Table Siegfried Ltd Company Details
Table Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business 2014-2019 (Million US$)
Figure Siegfried Ltd Revenue Growth Rate in Pharmaceutical CDMO Services Business (2014-2019)
Table Siegfried Ltd Recent Development
Table Fareva Group Company Details
Table FAMAR Health Care Services Company Details
Table Global Pharmaceutical CDMO Services Market Size by Regions (Million US$) 2019-2025
Figure Global Pharmaceutical CDMO Services Market Size Share by Regions (2019-2025)
Figure Global Pharmaceutical CDMO Services Market Size Share by Regions in 2025
Figure North America Pharmaceutical CDMO Services Market Size Forecast (2019-2025)(Million USD)
Figure Europe Pharmaceutical CDMO Services Market Size Forecast (2019-2025)(Million USD)
Figure China Pharmaceutical CDMO Services Market Size Forecast (2019-2025)(Million USD)
Figure Japan Pharmaceutical CDMO Services Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Pharmaceutical CDMO Services Market Size Forecast (2019-2025)(Million USD)
Figure India Pharmaceutical CDMO Services Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Pharmaceutical CDMO Services Market Size Forecast (2019-2025)(Million USD)
Table Global Pharmaceutical CDMO Services Market Size by Product (2019-2025) (Million US$)
Figure Global Pharmaceutical CDMO Services Market Size by Product (2019-2025)
Figure Global Pharmaceutical CDMO Services Market Size by Product in 2025
Table Global Pharmaceutical CDMO Services Market Size by Application (2019-2025) (Million US$)
Figure Global Pharmaceutical CDMO Services Market Size by Application (2019-2025)
Figure Global Pharmaceutical CDMO Services Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Recipharm AB、AMRI Global、Patheon N.V.、Aenova Group、Catalent, Inc.、Amatsigroup、WuXi AppTec Group、Strides Pharma Science Limited、Piramal Pharma Solutions、Siegfried Ltd、Fareva Group、FAMAR Health Care Services

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医薬品CDMOサービスの世界市場：規模・現状・予測(Global Pharmaceutical CDMO Services Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp